01 Jan Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations
Posted at 00:00h
in
Authored by: van Luin Matthijs, Gras Luuk, Richter Clemens, Ende Marchina E. van der, Prins Jan M., Wolf Frank de, Burger David M., Wit Ferdinand W.
In: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 52(2), 2009, p.240-245
http://www.ncbi.nlm.nih.gov/pubmed/19593159